Complexity of oxytocin's effects in a chronic cocaine dependent population

European Neuropsychopharmacology

Volumn 24, Issue 9, 2014, Pages 1483-1491

  Lee, Mary R ^a   Glassman, Matthew ^b   King Casas, Brooks ^c,d   Kelly, Deanna L ^b   Stein, Elliot A ^e   Schroeder, Jennifer ^f   Salmeron, Betty Jo ^e  

^a NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c VIRGINIA TECH CARILION SCHOOL OF MEDICINE   (United States)

^d VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

^e NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^f NIDA IRP   (United States)

Author keywords

Addiction; Cocaine; Cue reactivity; Oxytocin; Reward; Social cognition

Indexed keywords

AMFEBUTAMONE; ATOMOXETINE; OXYTOCIN; PLACEBO; SERTRALINE; VALPROIC ACID; NEUROLEPTIC AGENT;

ADULT; ANGER; ANXIETY; ARTICLE; ASSOCIATION; BECK DEPRESSION INVENTORY; CLINICAL ARTICLE; COCAINE DEPENDENCE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DECISION MAKING; DOUBLE BLIND PROCEDURE; DRUG DEPENDENCE TREATMENT; DRUG EFFECT; DRUG USE; DSM-IV-TR; EXCITABILITY; EXCITEMENT; FEMALE; HUMAN; IRRITABILITY; MALE; PILOT STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REINFORCEMENT; REWARD; SOCIAL COGNITION; TREATMENT OUTCOME; TREATMENT RESPONSE; WITHDRAWAL SYNDROME; ANALYSIS OF VARIANCE; CHRONIC DISEASE; CIRCADIAN RHYTHM; COCAINE-RELATED DISORDERS; COMPLICATION; DRUG EFFECTS; DRUG SEEKING BEHAVIOR; ETIOLOGY; INTRANASAL DRUG ADMINISTRATION; MIDDLE AGED; PAIN MEASUREMENT; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; QUESTIONNAIRE; SOCIAL BEHAVIOR; STATISTICAL MODEL; YOUNG ADULT;

ADMINISTRATION, INTRANASAL; ADULT; ANALYSIS OF VARIANCE; ANTIPSYCHOTIC AGENTS; ANXIETY; CHRONIC DISEASE; CIRCADIAN RHYTHM; COCAINE-RELATED DISORDERS; CROSS-OVER STUDIES; CUES; DECISION MAKING; DOUBLE-BLIND METHOD; DRUG-SEEKING BEHAVIOR; FEMALE; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; OXYTOCIN; PAIN MEASUREMENT; PSYCHIATRIC STATUS RATING SCALES; QUESTIONNAIRES; SOCIAL BEHAVIOR; YOUNG ADULT;

EID: 84907348613     PISSN: 0924977X     EISSN: 18737862     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2014.06.005     Document Type: Article

References (48)

1. Aharonovich E., Nguyen H.T., Nunes E.V. Anger and depressive states among treatment-seeking drug abusers: testing the psychopharmacological specificity hypothesis. Am. J. Addict. 2001, 10:327-334.
2. Allan S., Gilbert P. Anger and anger expression in relation to perceptions of social rank, entrapment and depressive symptoms. Personal. Individ. Differ. 2002, 32:551-565.
3. Baron-Cohen S., Ring H.A., Wheelwright S., Bullmore E.T., Brammer M.J., Simmons A., Williams S.C. Social intelligence in the normal and autistic brain: an fMRI study. Eur. J. Neurosci. 1999, 11:1891-1898.
4. Bartz J.A., Zaki J., Bolger N., Ochsner K.N. Social effects of oxytocin in humans: context and person matter. Trends Cogn. Sci. 2011, 15:301-309.
5. Bartz J.A., Zaki J., Ochsner K.N., Bolger N., Kolevzon A., Ludwig N., Lydon J.E. Effects of oxytocin on recollections of maternal care and closeness. Proc. Natl. Acad. Sci. USA 2010, 107:21371-21375.
6. Belin D., Mar A.C., Dalley J.W., Robbins T.W., Everitt B.J. High impulsivity predicts the switch to compulsive cocaine-taking. Science 2008, 320:1352-1355.
7. Born J., Lange T., Kern W., McGregor G.P., Bickel U., Fehm H.L. Sniffing neuropeptides: a transnasal approach to the human brain. Nat. Neurosci. 2002, 5:514-516.
8. Bowen M.T., Carson D.S., Spiro A., Arnold J.C., McGregor I.S. Adolescent oxytocin exposure causes persistent reductions in anxiety and alcohol consumption and enhances sociability in rats. PLoS One 2011, 6:e27237.
9. Burkett J.P., Young L.J. The behavioral, anatomical and pharmacological parallels between social attachment, love and addiction. Psychopharmacology (Berl) 2012, 224:1-26.
10. Carson D.S., Cornish J.L., Guastella A.J., Hunt G.E., McGregor I.S. Oxytocin decreases methamphetamine self-administration, methamphetamine hyperactivity, and relapse to methamphetamine-seeking behaviour in rats. Neuropharmacology 2010, 58:38-43.
11. Carson D.S., Guastella A.J., Taylor E.R., McGregor I.S. A brief history of oxytocin and its role in modulating psychostimulant effects. J. Psychopharmacol. 2013, 27:231-247.
12. De Moja C.A., Spielberger C.D. Anger and drug addiction. Psychol. Rep. 1997, 81:152-154.
13. Domes G., Heinrichs M., Michel A., Berger C., Herpertz S.C. Oxytocin improves "mind-reading" in humans. Biol. Psychiatry 2007, 61:731-733.
14. Flores P.J. Addiction as an attachment disorder: implications for group therapy. Int. J. Group Psychother. 2001, 51:63-81.
15. Fox H.C., Hong K.I., Siedlarz K., Sinha R. Enhanced sensitivity to stress and drug/alcohol craving in abstinent cocaine-dependent individuals compared to social drinkers. Neuropsychopharmacology 2008, 33:796-805.
16. Grillon C., Krimsky M., Charney D.R., Vytal K., Ernst M., Cornwell B. Oxytocin increases anxiety to unpredictable threat. Mol. Psychiatry 2013, 18:958-960.
17. Guzman Y.F., Tronson N.C., Jovasevic V., Sato K., Guedea A.L., Mizukami H., Nishimori K., Radulovic J. Fear-enhancing effects of septal oxytocin receptors. Nat. Neurosci. 2013, 16:1185-1187.
18. Insel T.R. Is social attachment an addictive disorder?. Physiol. Behav. 2003, 79:351-357.
19. Kirby K.N., Petry N.M., Bickel W.K. Heroin addicts have higher discount rates for delayed rewards than non-drug-using controls. J. Exp. Psychol. Gen. 1999, 128:78-87.
20. Kosfeld M., Heinrichs M., Zak P.J., Fischbacher U., Fehr E. Oxytocin increases trust in humans. Nature 2005, 435:673-676.
21. Kovacs G.L., Sarnyai Z., Szabo G. Oxytocin and addiction: a review. Psychoneuroendocrinology 1998, 23:945-962.
22. Liu Y., Aragona B.J., Young K.A., Dietz D.M., Kabbaj M., Mazei-Robison M., Nestler E.J., Wang Z. Nucleus accumbens dopamine mediates amphetamine-induced impairment of social bonding in a monogamous rodent species. Proc. Natl. Acad. Sci. USA 2010, 107:1217-1222.
23. Liu Y., Wang Z.X. Nucleus accumbens oxytocin and dopamine interact to regulate pair bond formation in female prairie voles. Neuroscience 2003, 121:537-544.
24. Liu Y., Young K.A., Curtis J.T., Aragona B.J., Wang Z. Social bonding decreases the rewarding properties of amphetamine through a dopamine D1 receptor-mediated mechanism. J. Neurosci. 2011, 31:7960-7966.
25. Macdonald E., Dadds M.R., Brennan J.L., Williams K., Levy F., Cauchi A.J. A review of safety, side-effects and subjective reactions to intranasal oxytocin in human research. Psychoneuroendocrinology 2011, 36:1114-1126.
26. Macdonald K., Macdonald T.M. The peptide that binds: a systematic review of oxytocin and its prosocial effects in humans. Harv. Rev. Psychiatry 2010, 18:1-21.
27. Macdonald K., Macdonald T.M., Brune M., Lamb K., Wilson M.P., Golshan S., Feifel D. Oxytocin and psychotherapy: a pilot study of its physiological, behavioral and subjective effects in males with depression. Psychoneuroendocrinology 2013, 38:2831-2843.
28. Marlatt G.A. Relapse prevention: Theoretical rationale and overview of the model. Relapse Prevention: Maintenance strategies in the treatment of addictive behaviors 1985, 3-67. Guilford Press, New York. G.A. Marlatt, J.R. Gordon (Eds.).
29. McGregor I.S., Bowen M.T. Breaking the loop: oxytocin as a potential treatment for drug addiction. Horm. Behav. 2012, 61:331-339.
30. McGregor I.S., Callaghan P.D., Hunt G.E. From ultrasocial to antisocial: a role for oxytocin in the acute reinforcing effects and long-term adverse consequences of drug use?. Br. J. Pharmacol. 2008, 154:358-368.
31. McRae-Clark A.L., Baker N.L., Maria M.M., Brady K.T. Effect of oxytocin on craving and stress response in marijuana-dependent individuals: a pilot study. Psychopharmacology (Berl) 2013, 228:623-631.
32. Meyer-Lindenberg A., Domes G., Kirsch P., Heinrichs M. Oxytocin and vasopressin in the human brain: social neuropeptides for translational medicine. Nat. Rev. Neurosci. 2011, 12:524-538.
33. Moll J., Krueger F., Zahn R., Pardini M., de Oliveira-Souza R., Grafman J. Human fronto-mesolimbic networks guide decisions about charitable donation. Proc. Natl. Acad. Sci. USA 2006, 103:15623-15628.
34. Pedersen C.A., Smedley K.L., Leserman J., Jarskog L.F., Rau S.W., Kampov-Polevoi A., Casey R.L., Fender T., Garbutt J.C. Intranasal oxytocin blocks alcohol withdrawal in human subjects. Alcohol Clin. Exp. Res. 2013, 37:484-489.
35. Pizzagalli D.A., Jahn A.L., O'Shea J.P. Toward an objective characterization of an anhedonic phenotype: a signal-detection approach. Biol. Psychiatry 2005, 57:319-327.
36. Qi J., Yang J.Y., Wang F., Zhao Y.N., Song M., Wu C.F. Effects of oxytocin on methamphetamine-induced conditioned place preference and the possible role of glutamatergic neurotransmission in the medial prefrontal cortex of mice in reinstatement. Neuropharmacology 2009, 56:856-865.
37. Santesso D.L., Evins A.E., Frank M.J., Schetter E.C., Bogdan R., Pizzagalli D.A. Single dose of a dopamine agonist impairs reinforcement learning in humans: evidence from event-related potentials and computational modeling of striatal-cortical function. Hum. Brain Mapp. 2009, 30:1963-1976.
38. Sarnyai Z., Kovacs G.L. Role of oxytocin in the neuroadaptation to drugs of abuse. Psychoneuroendocrinology 1994, 19:85-117.
39. Sirotich F. The criminal justice outcomes of jail diversion programs for persons with mental illness: a review of the evidence. J. Am. Acad. Psychiatry Law 2009, 37:461-472.
40. Spielberger C. Manual for the State-Trait Anxiety Inventory, Form Y 1983, Consulting Psychologists Press, Palo Alto, CA.
41. Striepens N., Kendrick K.M., Hanking V., Landgraf R., Wullner U., Maier W., Hurlemann R. Elevated cerebrospinal fluid and blood concentrations of oxytocin following its intranasal administration in humans. Sci. Rep. 2013, 3:3440.
42. Striepens N., Scheele D., Kendrick K.M., Becker B., Schafer L., Schwalba K., Reul J., Maier W., Hurlemann R. Oxytocin facilitates protective responses to aversive social stimuli in males. Proc. Natl. Acad. Sci. USA 2012, 109:18144-18149.
43. Volkow N.D., Wang G.J., Telang F., Fowler J.S., Logan J., Childress A.R., Jayne M., Ma Y., Wong C. Cocaine cues and dopamine in dorsal striatum: mechanism of craving in cocaine addiction. J. Neurosci. 2006, 26:6583-6588.
44. Walfish S., Massey R., Krone A. Anxiety and anger among abusers of different substances. Drug Alcohol Depend. 1990, 25:253-256.
45. Wong D.F., et al. Increased occupancy of dopamine receptors in human striatum during cue-elicited cocaine craving. Neuropsychopharmacology 2006, 31:2716-2727.
46. Yang J.Y., Qi J., Han W.Y., Wang F., Wu C.F. Inhibitory role of oxytocin in psychostimulant-induced psychological dependence and its effects on dopaminergic and glutaminergic transmission. Acta Pharmacol. Sin. 2010, 31:1071-1074.
47. Young K.A., Liu Y., Gobrogge K.L., Dietz D.M., Wang H., Kabbaj M., Wang Z. Amphetamine alters behavior and mesocorticolimbic dopamine receptor expression in the monogamous female prairie vole. Brain Res. 2011, 1367:213-222.
48. Young L.J., Wang Z. The neurobiology of pair bonding. Nat. Neurosci. 2004, 7:1048-1054.